633 results
Featured research: latest advances in mitral TEER and valve repair technologies
16 Nov 2025 – From PCR London Valves 2025
This session presents featured research on mitral valve interventions, including two-year outcomes from the MitraClip G4 EXPAND study, comparative data of mitral TEER versus redo surgery in failed surgical repair, evidence from novel TEER programs in non-surgical centers, and safety and efficacy results of the NeoNova...
Challenging mitral valve-in-valve
16 Nov 2025 – From PCR London Valves 2025
Gain insights into challenging mitral valve-in-valve procedures addressing small cavity anatomy, alignment difficulties, combined LAMPOON and leak closure techniques, and high-risk TMVR cases with complex left ventricular outflow tract obstruction and ECMO support.
Featured research: innovative solutions for mitral valve repair and replacement
16 Nov 2025 – From PCR London Valves 2025
This featured research session offers a comprehensive exploration of mitral valve interventions, encompassing electrosurgical device removal techniques, transcatheter mitral valve replacement (TMVR) outcomes, and transcatheter edge-to-edge repair (TEER) in complex clinical contexts such as heart transplantation and acute valve syndromes. It further examines pulmonary artery systolic...
Mitral valve-in-valve: high-left ventricular outflow tract obstruction risk
16 Nov 2025 – From PCR London Valves 2025
This session focuses on the management of high-risk left ventricular outflow tract (LVOT) obstruction in mitral valve-in-valve procedures. It discusses innovative approaches such as the tip-to-base LAMPOON procedure to mitigate obstruction risk, techniques for cutting obstructive tissue, and combined strategies involving sentinel-protected submitral aneurysm closure and...
Nightmare mitral interventions
16 Nov 2025 – From PCR London Valves 2025
This session presents complex mitral valve intervention cases highlighting procedural challenges and innovative solutions. It includes management of embolised transcatheter mitral valve replacements (TMVR), bailout redo transcatheter edge-to-edge repair (TEER), complications such as acute hypoxia and atrial wall perforations, and the application of TAVI skills in...
Curious mitral and tricuspid scenarios
16 Nov 2025 – From PCR London Valves 2025
This session presents a series of challenging and unusual clinical scenarios involving mitral and tricuspid valve disease. Topics include management of acute primary mitral regurgitation in high-surgical-risk patients, technical challenges in transcatheter mitral valve replacement (TMVR), and complex cases where cardiac rhythm disturbances interplay with valvular...
The Silk Road of MedTech
16 Nov 2025 – From PCR London Valves 2025
Discover pioneering MedTech innovations along the Silk Road, including novel sheath designs for minimalist TAVR, self-expanding valves for pure aortic regurgitation, automated CT quantification via deep learning, and first-in-man experiences with cutting-edge valvuloplasty and TEER devices.
Mitral TEER - LIVE Case
16 Nov 2025 – From PCR London Valves 2025
Watch this live case followed by a recorded case, regarding a 75-year-old male with type 2 DM, permanent AF, and severe LV dysfunction (30%), with a history of RCA PCI one month earlier and three hospitalizations for heart failure, presented with severe secondary mitral and tricuspid...
Hotline - Mitral and tricuspid valvular interventions
16 Nov 2025 – From PCR London Valves 2025
This session delves into innovative mitral and tricuspid valvular interventions, highlighting outcomes with the PASCAL precision system and advances in combined MitraClip and TriClip repairs. It discusses predictors of heart failure hospitalization post-transcatheter tricuspid valve repair (TTVR), coronary CT-based pacemaker implantation prediction, and novel devices aimed...
Shaping the future: top innovations at PCR London Valves 2025
16 Nov 2025 – From PCR London Valves 2025
Highlighting transformative innovations from PCR London Valves 2025, this session features advanced technologies such as the Luna TMVR with its unique intuitive design, the novel Tripair technology for tricuspid therapy, and insights into right heart remodeling following transcatheter tricuspid valve interventions with the DUO system, showcasing...